Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RYAN MATTHEW LINGLE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1891290631
CMS profile
8805899
Location
LA PORTE, IN

General Payments · PY2020–2024

$2,380.26

  • Reported across 140 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$824.38

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $824.38 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $14.26 1
PY2021 $67.51 4
PY2022 $556.36 42
PY2023 $917.75 55
PY2024 $824.38 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.37 09/20/2024 Food and Beverage Undisputed 01/23/2026 1104886965 CMS
ABBVIE INC. $26.08 09/27/2024 Food and Beverage Undisputed 01/23/2026 1104886967 CMS
Amgen Inc. $14.33 07/18/2024 Food and Beverage Undisputed 01/23/2026 1115875442 CMS
Astellas Pharma US Inc $16.72 10/14/2024 Food and Beverage Undisputed 01/23/2026 1139409719 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.66 09/24/2024 Food and Beverage Undisputed 01/23/2026 1086180903 CMS
GlaxoSmithKline, LLC. $14.40 01/24/2024 Food and Beverage Undisputed 01/23/2026 1116201541 CMS
IDORSIA PHARMACEUTICALS US INC $13.55 10/01/2024 Food and Beverage Undisputed 01/23/2026 1146781414 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.35 02/27/2024 Food and Beverage Undisputed 01/23/2026 1143266010 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.46 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143266014 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.25 12/21/2024 Food and Beverage Undisputed 01/23/2026 1143266018 CMS
Lilly USA, LLC $23.28 05/17/2024 Food and Beverage Undisputed 01/23/2026 1135379178 CMS
Lilly USA, LLC $20.94 06/03/2024 Food and Beverage Undisputed 01/23/2026 1135382145 CMS
Lilly USA, LLC $20.71 08/22/2024 Food and Beverage Undisputed 01/23/2026 1135407046 CMS
Lilly USA, LLC $22.05 10/25/2024 Food and Beverage Undisputed 01/23/2026 1135340425 CMS
Lundbeck LLC $28.24 03/19/2024 Food and Beverage Undisputed 01/23/2026 1145939936 CMS
Lundbeck LLC $13.32 06/08/2024 Food and Beverage Undisputed 01/23/2026 1145939938 CMS
Lundbeck LLC $24.88 06/14/2024 Food and Beverage Undisputed 01/23/2026 1145939940 CMS
Lundbeck LLC $21.90 09/17/2024 Food and Beverage Undisputed 01/23/2026 1145939942 CMS
Mylan Specialty L.P. $25.73 05/21/2024 Food and Beverage Undisputed 01/23/2026 1147374781 CMS
Mylan Specialty L.P. $21.98 10/01/2024 Food and Beverage Undisputed 01/23/2026 1147297971 CMS
Novartis Pharmaceuticals Corporation $14.06 03/12/2024 Food and Beverage Undisputed 01/23/2026 1087034812 CMS
Novartis Pharmaceuticals Corporation $14.26 06/11/2024 Food and Beverage Undisputed 01/23/2026 1087034820 CMS
Novo Nordisk Inc $14.91 01/25/2024 Food and Beverage Undisputed 01/23/2026 1097815484 CMS
Novo Nordisk Inc $21.70 06/04/2024 Food and Beverage Undisputed 01/23/2026 1097045919 CMS
Novo Nordisk Inc $23.15 07/23/2024 Food and Beverage Undisputed 01/23/2026 1096608752 CMS
Novo Nordisk Inc $20.35 10/24/2024 Food and Beverage Undisputed 01/23/2026 1096939123 CMS
Novo Nordisk Inc $17.29 11/02/2024 Food and Beverage Undisputed 01/23/2026 1097110204 CMS
Novo Nordisk Inc $18.05 12/17/2024 Food and Beverage Undisputed 01/23/2026 1097046277 CMS
Otsuka America Pharmaceutical, Inc. $14.31 02/20/2024 Food and Beverage Undisputed 01/23/2026 1118931156 CMS
Otsuka America Pharmaceutical, Inc. $20.07 05/31/2024 Food and Beverage Undisputed 01/23/2026 1118931158 CMS
PFIZER INC. $15.28 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131115631 CMS
PFIZER INC. $21.92 07/30/2024 Food and Beverage Undisputed 01/23/2026 1131789767 CMS
PFIZER INC. $15.71 09/25/2024 Food and Beverage Undisputed 01/23/2026 1131940895 CMS
PFIZER INC. $15.03 10/09/2024 Food and Beverage Undisputed 01/23/2026 1132125051 CMS
Phathom Pharmaceuticals, Inc. $18.71 05/16/2024 Food and Beverage Undisputed 01/23/2026 1151089479 CMS
Sumitomo Pharma America, Inc. $22.61 03/18/2024 Food and Beverage Undisputed 01/23/2026 1148882414 CMS
Supernus Pharmaceuticals, Inc. $24.97 01/26/2024 Food and Beverage Undisputed 01/23/2026 1147865080 CMS
Supernus Pharmaceuticals, Inc. $112.80 01/26/2024 Food and Beverage Undisputed 01/23/2026 1147865082 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.